These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 20510104

  • 1. [Efficacy of lower dose rituximab therapy for idiopathic thrombocytopenic purpura.].
    Sui T, Xue F, Zhao HF, Ge J, Zhou H, Zhang L, Bai J, Yang RC.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):161-3. PubMed ID: 20510104
    [Abstract] [Full Text] [Related]

  • 2. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y, Wang XM, Mao M, Zhang XY, Fu L, Ai HM, Zhang LX.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
    [Abstract] [Full Text] [Related]

  • 3. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W, Yu QH, Zhang HY, Chu XX, Chen F, Zhang CQ, Zhou YH, Hou M.
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [Abstract] [Full Text] [Related]

  • 4. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
    Zhu YC, Wang W, Zhou YH, Wang XM, Wang X, Wang YL, Sun GZ, Hou M.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
    [Abstract] [Full Text] [Related]

  • 5. [Absence of response to rituximab in patients with refractory primary immune thrombocytopenia].
    Ma H, Wang Y, Sun L, Gong H.
    Zhonghua Yi Xue Za Zhi; 2014 Oct 21; 94(38):3011-3. PubMed ID: 25547706
    [Abstract] [Full Text] [Related]

  • 6. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
    Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.
    Eur J Haematol; 2002 Aug 21; 69(2):95-100. PubMed ID: 12366712
    [Abstract] [Full Text] [Related]

  • 7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr 21; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 8. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J.
    Br J Haematol; 2014 Oct 21; 167(2):243-51. PubMed ID: 25041261
    [Abstract] [Full Text] [Related]

  • 9. Study of platelet-associated immunoglobulins of IgG, IgM, IgA, and IgE classes and platelet kinetics in 33 patients with idiopathic thrombocytopenic purpura.
    Movahed Shariat Panahi MR, Le Blanc S, Schober O, Coldewey R, Deicher H.
    Ann Hematol; 1994 Sep 21; 69(3):121-8. PubMed ID: 8086506
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children.
    Dai WJ, Zhang RR, Yang XC, Yuan YF.
    Eur Rev Med Pharmacol Sci; 2015 Jul 21; 19(13):2379-83. PubMed ID: 26214772
    [Abstract] [Full Text] [Related]

  • 11. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.
    Blood Coagul Fibrinolysis; 2016 Jun 21; 27(4):431-5. PubMed ID: 26656905
    [Abstract] [Full Text] [Related]

  • 12. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.
    Int J Hematol; 2006 Jul 21; 84(1):48-53. PubMed ID: 16867902
    [Abstract] [Full Text] [Related]

  • 13. Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura.
    Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N, Amadori S.
    Blood; 2007 Oct 15; 110(8):2924-30. PubMed ID: 17548576
    [Abstract] [Full Text] [Related]

  • 14. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 15; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 15. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
    Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB.
    Br J Haematol; 2012 Aug 15; 158(4):539-47. PubMed ID: 22775462
    [Abstract] [Full Text] [Related]

  • 16. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 Aug 15; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 17. [Clinical therapeutic efficacy of rituximab for relapsed and refractory idiopathic thrombocytopenic purpura].
    Zhou LY, Zhang Z, Song LX, Gzhang X, Su JY, Li X, Chang CK.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug 15; 20(4):941-4. PubMed ID: 22931660
    [Abstract] [Full Text] [Related]

  • 18. Immunological characteristics and effect of cyclosporin in patients with immune thrombocytopenia.
    Wang T, He X, Ran N, Liu C, Xing L, Wang H, Fu R, Shao Z.
    J Clin Lab Anal; 2021 Sep 15; 35(9):e23922. PubMed ID: 34329516
    [Abstract] [Full Text] [Related]

  • 19. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
    Gall B, Yee A, Berry B, Bircham D, Hayashi A, Dansereau J, Hart J.
    J Obstet Gynaecol Can; 2010 Dec 15; 32(12):1167-1171. PubMed ID: 21176329
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 15; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.